{"id":402632,"date":"2025-11-25T02:28:11","date_gmt":"2025-11-25T02:28:11","guid":{"rendered":"https:\/\/www.europesays.com\/us\/402632\/"},"modified":"2025-11-25T02:28:11","modified_gmt":"2025-11-25T02:28:11","slug":"n-j-pharmacist-admits-2-5m-fraud-scheme-involving-diarrhea-drug","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/402632\/","title":{"rendered":"N.J. pharmacist admits $2.5M fraud scheme involving diarrhea drug"},"content":{"rendered":"

A Paterson pharmacy owner recently pleaded guilty to health care fraud for submitting $2.5 million in Medicare reimbursements for a diarrhea drug he never dispensed, the U.S. Attorney\u2019s Office announced Monday.<\/p>\n

Nestor E. Jaime<\/a>, 37, of Pine Brook in Montville, agreed to the guilty plea on Nov. 19 in federal court in Newark. Authorities announced the charges<\/a> in July.<\/p>\n

Jaime filed for the reimbursements from December 2019 to December 2021 at his pharmacy, which records show was called Fabio\u2019s Pharmacy and is now closed.<\/p>\n

Court papers say he used some of the money to pay personal expenses, including his mortgage and credit card accounts, and $1 million went to lease luxury vehicles and to purchase high-end watches and entertainment.<\/p>\n

Federal investigators found Jaime filed approximately 591 false or fraudulent claims to Medicare for the drug Dificid<\/a>, which doctors prescribe to treat diarrhea. The claims were on the high end of the drug\u2019s price range, about $4,500 per prescription.<\/p>\n

If the claims were legitimate, the pharmacy would have needed to dispense at least 11,820 units of Dificid. However, his pharmacy only ever purchased approximately 100 units.<\/p>\n

Jaime\u2019s lawyer did not immediately return a message seeking comment. <\/p>\n","protected":false},"excerpt":{"rendered":"A Paterson pharmacy owner recently pleaded guilty to health care fraud for submitting $2.5 million in Medicare reimbursements…\n","protected":false},"author":3,"featured_media":402633,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[13890,190416,1230,210,1141,1142,27500,177301,3535,67,132,68],"class_list":{"0":"post-402632","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health-care","8":"tag-bottle","9":"tag-capsules","10":"tag-drugs","11":"tag-health","12":"tag-health-care","13":"tag-healthcare","14":"tag-pharmacy","15":"tag-pills","16":"tag-prescription","17":"tag-united-states","18":"tag-unitedstates","19":"tag-us"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/402632","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=402632"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/402632\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/402633"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=402632"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=402632"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=402632"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}